Clinical Trial Update: Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)

View source ↗

Summary

Biogen is conducting a pregnancy exposure registry for Vumerity (diroximel fumarate) in people with multiple sclerosis. Enrollment is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• VUMERITY (diroximel fumarate)

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis | Status: RECRUITING